The global mRNA COVID-19 Vaccine market size is expected to reach $ 4745.9 million by 2029, rising at a market growth of 1.2% CAGR during the forecast period (2023-2029).
This report studies the global mRNA COVID-19 Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA COVID-19 Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA COVID-19 Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global mRNA COVID-19 Vaccine total production and demand, 2018-2029, (K Units)
Global mRNA COVID-19 Vaccine total production value, 2018-2029, (USD Million)
Global mRNA COVID-19 Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global mRNA COVID-19 Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: mRNA COVID-19 Vaccine domestic production, consumption, key domestic manufacturers and share
Global mRNA COVID-19 Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global mRNA COVID-19 Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global mRNA COVID-19 Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global mRNA COVID-19 Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, CanSino Biologicals, Pfizer, Fosun-Pharmaceutical and CSPC Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA COVID-19 Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global mRNA COVID-19 Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global mRNA COVID-19 Vaccine Market, Segmentation by Type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Global mRNA COVID-19 Vaccine Market, Segmentation by Application
Children
Adults
Companies Profiled:
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Key Questions Answered
1. How big is the global mRNA COVID-19 Vaccine market?
2. What is the demand of the global mRNA COVID-19 Vaccine market?
3. What is the year over year growth of the global mRNA COVID-19 Vaccine market?
4. What is the production and production value of the global mRNA COVID-19 Vaccine market?
5. Who are the key producers in the global mRNA COVID-19 Vaccine market?
6. What are the growth factors driving the market demand?
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Supply Summary
1.1 mRNA COVID-19 Vaccine Introduction
1.2 World mRNA COVID-19 Vaccine Supply & Forecast
1.2.1 World mRNA COVID-19 Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World mRNA COVID-19 Vaccine Production (2018-2029)
1.2.3 World mRNA COVID-19 Vaccine Pricing Trends (2018-2029)
1.3 World mRNA COVID-19 Vaccine Production by Region (Based on Production Site)
1.3.1 World mRNA COVID-19 Vaccine Production Value by Region (2018-2029)
1.3.2 World mRNA COVID-19 Vaccine Production by Region (2018-2029)
1.3.3 World mRNA COVID-19 Vaccine Average Price by Region (2018-2029)
1.3.4 North America mRNA COVID-19 Vaccine Production (2018-2029)
1.3.5 Europe mRNA COVID-19 Vaccine Production (2018-2029)
1.3.6 China mRNA COVID-19 Vaccine Production (2018-2029)
1.3.7 Japan mRNA COVID-19 Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA COVID-19 Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA COVID-19 Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 Demand Summary
2.1 World mRNA COVID-19 Vaccine Demand (2018-2029)
2.2 World mRNA COVID-19 Vaccine Consumption by Region
2.2.1 World mRNA COVID-19 Vaccine Consumption by Region (2018-2023)
2.2.2 World mRNA COVID-19 Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States mRNA COVID-19 Vaccine Consumption (2018-2029)
2.4 China mRNA COVID-19 Vaccine Consumption (2018-2029)
2.5 Europe mRNA COVID-19 Vaccine Consumption (2018-2029)
2.6 Japan mRNA COVID-19 Vaccine Consumption (2018-2029)
2.7 South Korea mRNA COVID-19 Vaccine Consumption (2018-2029)
2.8 ASEAN mRNA COVID-19 Vaccine Consumption (2018-2029)
2.9 India mRNA COVID-19 Vaccine Consumption (2018-2029)
3 World mRNA COVID-19 Vaccine Manufacturers Competitive Analysis
3.1 World mRNA COVID-19 Vaccine Production Value by Manufacturer (2018-2023)
3.2 World mRNA COVID-19 Vaccine Production by Manufacturer (2018-2023)
3.3 World mRNA COVID-19 Vaccine Average Price by Manufacturer (2018-2023)
3.4 mRNA COVID-19 Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA COVID-19 Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA COVID-19 Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for mRNA COVID-19 Vaccine in 2022
3.6 mRNA COVID-19 Vaccine Market: Overall Company Footprint Analysis
3.6.1 mRNA COVID-19 Vaccine Market: Region Footprint
3.6.2 mRNA COVID-19 Vaccine Market: Company Product Type Footprint
3.6.3 mRNA COVID-19 Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: mRNA COVID-19 Vaccine Production Value Comparison
4.1.1 United States VS China: mRNA COVID-19 Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: mRNA COVID-19 Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: mRNA COVID-19 Vaccine Production Comparison
4.2.1 United States VS China: mRNA COVID-19 Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: mRNA COVID-19 Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: mRNA COVID-19 Vaccine Consumption Comparison
4.3.1 United States VS China: mRNA COVID-19 Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: mRNA COVID-19 Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based mRNA COVID-19 Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based mRNA COVID-19 Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA COVID-19 Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers mRNA COVID-19 Vaccine Production (2018-2023)
4.5 China Based mRNA COVID-19 Vaccine Manufacturers and Market Share
4.5.1 China Based mRNA COVID-19 Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA COVID-19 Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers mRNA COVID-19 Vaccine Production (2018-2023)
4.6 Rest of World Based mRNA COVID-19 Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based mRNA COVID-19 Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA COVID-19 Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers mRNA COVID-19 Vaccine Production (2018-2023)
5 Market Analysis by Type
5.1 World mRNA COVID-19 Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-replicating mRNA Vaccine
5.2.2 Self-amplifying mRNA Vaccine
5.3 Market Segment by Type
5.3.1 World mRNA COVID-19 Vaccine Production by Type (2018-2029)
5.3.2 World mRNA COVID-19 Vaccine Production Value by Type (2018-2029)
5.3.3 World mRNA COVID-19 Vaccine Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World mRNA COVID-19 Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Children
6.2.2 Adults
6.3 Market Segment by Application
6.3.1 World mRNA COVID-19 Vaccine Production by Application (2018-2029)
6.3.2 World mRNA COVID-19 Vaccine Production Value by Application (2018-2029)
6.3.3 World mRNA COVID-19 Vaccine Average Price by Application (2018-2029)
7 Company Profiles
7.1 Moderna
7.1.1 Moderna Details
7.1.2 Moderna Major Business
7.1.3 Moderna mRNA COVID-19 Vaccine Product and Services
7.1.4 Moderna mRNA COVID-19 Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Moderna Recent Developments/Updates
7.1.6 Moderna Competitive Strengths & Weaknesses
7.2 CanSino Biologicals
7.2.1 CanSino Biologicals Details
7.2.2 CanSino Biologicals Major Business
7.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Product and Services
7.2.4 CanSino Biologicals mRNA COVID-19 Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 CanSino Biologicals Recent Developments/Updates
7.2.6 CanSino Biologicals Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer mRNA COVID-19 Vaccine Product and Services
7.3.4 Pfizer mRNA COVID-19 Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Fosun-Pharmaceutical
7.4.1 Fosun-Pharmaceutical Details
7.4.2 Fosun-Pharmaceutical Major Business
7.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product and Services
7.4.4 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Fosun-Pharmaceutical Recent Developments/Updates
7.4.6 Fosun-Pharmaceutical Competitive Strengths & Weaknesses
7.5 CSPC Pharmaceutical
7.5.1 CSPC Pharmaceutical Details
7.5.2 CSPC Pharmaceutical Major Business
7.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product and Services
7.5.4 CSPC Pharmaceutical mRNA COVID-19 Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 CSPC Pharmaceutical Recent Developments/Updates
7.5.6 CSPC Pharmaceutical Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 mRNA COVID-19 Vaccine Industry Chain
8.2 mRNA COVID-19 Vaccine Upstream Analysis
8.2.1 mRNA COVID-19 Vaccine Core Raw Materials
8.2.2 Main Manufacturers of mRNA COVID-19 Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 mRNA COVID-19 Vaccine Production Mode
8.6 mRNA COVID-19 Vaccine Procurement Model
8.7 mRNA COVID-19 Vaccine Industry Sales Model and Sales Channels
8.7.1 mRNA COVID-19 Vaccine Sales Model
8.7.2 mRNA COVID-19 Vaccine Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
*If Applicable.